Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Laparoscopic sentinel lymph node biopsy and stomach preserving surgery in ealry gastric cancer is less invasive method which can increase quality of life. Multicenter phase III trial is requred to validate this method. In this study all items which are necessary for laparoscopic sentinel lymph node biopsy are identified according to checklist and evaluated the performance completement.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Laparoscopic sentinel lymph node biopsy | Experimental | This is a single armed study. After endoscopic marking using Tc99m HSA and indocyanine green fluid, Laparoscopic sentinel lymph node biopsy was performed and evalute at backtable. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Laparoscopic sentinel lymph node biopsy | Procedure | During the operation, endoscopic marking was perfomed using Tc 99m HSA and indocyanine green around tumor. Then we identify the sentinel lymph node with laparoscopic probe. Laparoscopic sentinel lymph nodes were dissedted and evaluated them at the backtable in the operating room. |
| Measure | Description | Time Frame |
|---|---|---|
| Completement of performance of laparoscopic sentinel lymph node biopsy | Investigators will make out a checklist after operation for evaluating the completement of performance of laparoscopic sentinel lymph node biopsy. The checklist will be made out within 24 hours. | within 24 hours after operation |
| Measure | Description | Time Frame |
|---|---|---|
| Detection rate of laparoscopic sentinel lymph node, learning curve | Detection rate of laparoscopic sentinel lymph node is evaluated within 7 days after operation by pathological examination. Learning curve can be drawn after all cases' data are collected, so it takes upto 2 years. | upto 2 years |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Keun Won Ryu, Doctor | National Cancer Center, Korea | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Chonnam National University Hwasun Hospital | Hwasun | Chonnam | South Korea | |||
| National Cancer Center, Korea |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
|
| Goyang-si |
| Gyeonggi-do |
| 410-769 |
| South Korea |
| Ajou University School of Medicine | Suwon | Gyeonggi-do | South Korea |
| Gyeongsang National University | Jinju | Gyeongsangnam-do | South Korea |
| Korea University Guro Hospital | Seoul | Seoul | South Korea |
| Yonsei Univeristy College of Medicine | Seoul | Seoul | South Korea |
| Hallym University Sacred Heart Hospital | Anyang | South Korea |
| Soonchunhyang University Bucheon Hospital | Bucheon-si | South Korea |
| Dong-A University College of Medicine | Busan | South Korea |
| Dongnam Institute of Radiological and Medical Science | Busan | South Korea |
| Keimyung University School of Medicine | Daegu | South Korea |
| Korea University College of Medicine | Seoul | South Korea |
| Kyung Hee University Gangdong Hospital | Seoul | South Korea |
| Seoul St. Mary's Hospital | Seoul | South Korea |
| Yeouido St. Mary's Hospital | Seoul | South Korea |
| ID | Term |
|---|---|
| D013274 | Stomach Neoplasms |
| ID | Term |
|---|---|
| D005770 | Gastrointestinal Neoplasms |
| D004067 | Digestive System Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D004066 | Digestive System Diseases |
| D005767 | Gastrointestinal Diseases |
| D013272 | Stomach Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D007208 | Indocyanine Green |
| ID | Term |
|---|---|
| D007211 | Indoles |
| D006574 | Heterocyclic Compounds, 2-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
| D006571 | Heterocyclic Compounds |
Not provided
Not provided